Want to join the conversation?
David Glick from Buckingham Research probes on whey the guidance appears to be at a lower growth rate in 2H16 on Calvin Klein. $PVH said that in the US the company is taking a prudent posture. The company is expecting the sales trends in 1Q16 to continue for the balance of the year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?